Need for greater patient and clinician involvement in comparative clinical effectiveness research

April 17, 2012 in Health

More involvement by patients, clinicians and others in the health care community in developing comparative clinical effectiveness research studies will make such studies far more useful in clinical decision-making, according to the Patient-Centered Outcomes Research Institute, in an article published in the April 18 issue of JAMA, a theme issue on comparative effectiveness research.

Anne C. Beal, M.D., M.P.H., of the Patient-Centered Outcomes Research Institute (PCORI), Washington, D.C., presented the article at a JAMA media briefing at the National Press Club.

The and Act of 2010 created PCORI to fund and promote comparative clinical (CER) that will "assist patients, , purchasers, and in making informed by advancing the quality and relevance of evidence concerning the manner in which diseases, disorders, and other can effectively and appropriately be prevented, diagnosed, treated, monitored, and managed through research and evidence synthesis," according to information in the article.

The institute developed a definition of patient-centered outcomes research that emphasizes the voice of the patient in assessing options. "The PCORI mission statement commits to producing and promoting high-integrity research that is 'guided by patients, caregivers, and the broader healthcare community.' The institute's first funding announcement solicited projects focused on methods for engaging patients and other stakeholders in all aspects of the research process," Dr. Beal and colleagues write. There have been more than 800 responses to this announcement, with merit review currently being conducted. The process has been modified in 2 ways: 1) stakeholders, including patients, caregivers, and clinicians, were invited via the PCORI website to sign up if they were interested in participating in the merit reviews; 2) proposed scoring criteria included an additional criterion - extent of patient engagement.

The founding legislation required PCORI to develop national priorities for research and a research agenda, and to post both for a 45- to 60-day public comment period before major funding for research could begin. The development process extended from July to December 2011, and included examination of other recent prioritization efforts and input received through discussions with stakeholder groups, including patients and their caregivers, clinicians, hospitals and health care systems, payers, the life sciences industry, and the research community. The process produced 5 national priorities, which are: 1) assessment of options for prevention, diagnosis, and treatment; 2) improving health care systems; 3) dissemination and communications research; 4) addressing disparities; and 5) accelerating patient-centered outcomes research and methodology. "The national priorities encompass many research areas cited by earlier priority-setting groups, but add a patient-centered perspective," the authors note.

According to the authors, transparency is a key principle for PCORI, and the public comment period included collection of input through an online survey, discussion with individuals through focus groups conducted throughout the United States, and a national dialogue event and webcast midway through the comment period. Analysis of this input and resulting revisions to the priorities and agenda are under way and the initial funding announcements are expected in May 2012. "Applicants will be instructed to explain how their proposed research aligns with the statutory criteria and to describe how patients and other stakeholders will be engaged in and benefit from the research. The initial portfolio of funded research is expected to cover a range of conditions and interventions, to be exemplary of stakeholder-engaged research, and to be highly aligned with the criteria."

"The proposition that greater involvement of patients, clinicians, and others in the research process could help reorient the clinical research enterprise, reduce clinical uncertainty, and speed adoption of meaningful findings holds great promise, but remains to be tested. PCORI will test this hypothesis. The underlying imperative is to improve patients' care experience, decision making, and health outcomes. Patients as well as the physicians and other health care professionals who care for and about them are invited and encouraged to join in this effort," the authors conclude.

More information: JAMA. 2012;307[15]:1583-1584.

Journal reference:

Provided by JAMA and Archives Journals search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Driving and hands-free talking lead to spike in errors, study shows

Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.

Health created 23 hours ago | popularity not rated yet | comments 1

About one in four uninsured could be excluded from ACA

(HealthDay)—More than one in four of those eligible for new premium assistance tax credits under the Affordable Care Act (ACA) do not have a checking account and will not be able to receive premiums from ...

Health created May 24, 2013 | popularity not rated yet | comments 0

Audiologists recommend smart phone apps to monitor noise levels

After studying noise in one French Quarter neighborhood of New Orleans to determine whether or not noise levels exceeded municipal ordinances, Annette Hurley, PhD, Assistant Professor of Audiology at LSU Health Sciences Center ...

Health created May 24, 2013 | popularity not rated yet | comments 0

Young children who miss well-child visits are more likely to be hospitalized

Young children who missed more than half of recommended well-child visits had up to twice the risk of hospitalization compared to children who attended most of their visits, according to a study published today in the American Jo ...

Health created May 24, 2013 | popularity not rated yet | comments 0

Do doctors understand the individualisation of treatments?

The individualisation of drug treatments to support patients to self-manage their conditions is a concept that sits at the heart of policy, but a recent study in BMJ Open shows that there is no concrete defini ...

Health created May 24, 2013 | popularity 3 / 5 (1) | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.